Position
Chief AI Officer
Company
H. Lundbeck A/S
CopenhagenBiotechnologyHealth CarePharmaceuticalDescription
H. Lundbeck A/S has announced the appointment of Markus Kede as Senior Vice President, Chief AI Officer. He is expected to join the Executive Leadership Team by July 1, 2026, to lead the company's global AI strategy.
Other recent leadership changes in Pharmaceutical and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Santhera Pharmaceuticals Appoints Marc Clausse as Chief Commercial Officer (March 10, 2026)
- MBX Biosciences Appoints Karen Basbaum as Chief Business Officer (March 10, 2026)
- West Pharmaceutical Services, Inc. Announces Eric M. Green's Upcoming Retirement as CEO (March 9, 2026)
- Ratio Therapeutics Appoints Colin Hayward as Chief Medical Officer (March 12, 2026)
- Halozyme Appoints David Ramsay as Interim Chief Financial Officer (March 12, 2026)
- Orexo Appoints Lisa Moore as Senior Vice President, Products and Portfolio Strategy (March 6, 2026)
Who to call at H. Lundbeck A/S, and when
A new leader at H. Lundbeck A/S brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day H. Lundbeck A/S raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at H. Lundbeck A/S, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at H. Lundbeck A/S. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment H. Lundbeck A/S changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
H. Lundbeck A/S changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.